Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TITAN PHARMACEUTICALS INC Director's Dealing 2005

Dec 7, 2005

35418_dirs_2005-12-07_de4993e5-4e76-4d68-8db9-09f16fcf2116.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (AMEX - TTP)
CIK: 0000910267
Period of Report: 2005-12-06

Reporting Person: ALLEN RICHARD C (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-12-06 Common Stock S 26488 $1.30 Disposed 20000 Direct
2005-12-06 Common Stock S 6500 $1.31 Disposed 13500 Direct
2005-12-06 Common Stock S 13500 $1.33 Disposed 0 Direct